Detailed price information for Inhibikase Therapeutics Inc (IKT-Q) from The Globe and Mail including charting and trades.
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, ...
Nadja Spiegelman: Did woke go too far? I’ve noticed some people are saying the R-word again, and pronouns and emails no ...
CHAPEL HILL, N.C., March 10, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company ...
Viridian Therapeutics (VRDN) remains a 'Sell' as both lead TED assets underperform versus Amgen’s Tepezza, with limited ...
Donald Trump promised to usher in a new era of offshore oil drilling. Scientists know all too well how that story ends.
Analyst/Investor Day March 31, 2026 12:00 PM EDTCompany ParticipantsAnoori Naughton - Vice President of Investor ...
Dining out can cost a small fortune when you are visiting fine dining establishments. This is even more true when they ...
Since 2007, Jezebel has been the Internet's most treasured source for everything celebrities, sex, and politics...with teeth.
Guidance for local, state, and federal government authorities on responding to protests and demonstrations, including ...
FPX Nickel Corp. (TSX-V: FPX, OTCQB: FPOCF) ("FPX" or the "Company") is pleased to announce the results from a large-scale ...
Background Hypertrophic cardiomyopathy (HCM) is associated with an increased risk of sudden cardiac death (SCD), and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results